Overview
Ken Tajima practices in Tokyo, Japan. Mr. Tajima is rated as an Experienced expert by MediFind in the treatment of Tracheobronchopathia Osteoplastica. His top areas of expertise are Lung Cancer, Tracheobronchopathia Osteoplastica, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.
His clinical research consists of co-authoring 31 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Tracheobronchopathia Osteoplastica.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung CancerMr. Tajima isAdvanced. Learn about Lung Cancer.
- Experienced
- Cerebral HypoxiaMr. Tajima isExperienced. Learn about Cerebral Hypoxia.
- EGFR Positive Lung CancerMr. Tajima isExperienced. Learn about EGFR Positive Lung Cancer.
- Neuroendocrine TumorMr. Tajima isExperienced. Learn about Neuroendocrine Tumor.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Tajima isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Pulmonary FibrosisMr. Tajima isExperienced. Learn about Pulmonary Fibrosis.
- Small Cell Lung Cancer (SCLC)Mr. Tajima isExperienced. Learn about Small Cell Lung Cancer (SCLC).